Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Genzyme Announces Agreement to Sell Diagnostics Business
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Pfizer Launches Global Centers for Therapeutic Innovation
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](/images/stories/logo/pfizer_b.gif)
Roche announces implementation plans for its Operational Excellence Program
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Boehringer Ingelheim steps up to the challenge in support of World Diabetes Day
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](/images/stories/logo/pfizer_b.gif)
Rivaroxaban Significantly Reduces Risk of Stroke with Comparable Safety versus Warfarin
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
More Pharma News ...
- Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions
- Collaboration of Boehringer Ingelheim and VTU Technology
- Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America's Type 2 Diabetes Crisis
- Nycomed is keeping the pace in third quarter 2010
- Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent
- Roche reports promising Phase II results with new targeted approach in advanced melanoma
- Genzyme Responds to Sanofi-Aventis Letter